All In MedTech

Company

Allurion Technologies

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$36.1M

7 Form D offerings, 2012 to 2025

Equity

$28.7M

Stock sold for cash

Debt and convertible notes

$0

Loans and notes sold to investors

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: equity, $5.0M raised of $5.0M sought, first sale Nov 14, 2025, 16 investors. $7.4M was in other or unstated securities.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Nov 14, 2025Equity$5.0M$5.0M16Rule 506(b)Agent: Roth Capital Partners, LLCCommissions $350KForm D ↗Nov 26, 2025
Jan 27, 2025Options or warrants$7.4M$7.4M14Rule 506(b)Agent: Roth Capital Partners, LLCCommissions $521KForm D ↗Feb 7, 2025
Dec 18, 2023Equity$123K$100M1Rule 506(b)Form D ↗Dec 22, 2023

4 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
ALLURION TECHNOLOGIES, INC.; Allurion Technologies, Inc.
Headquarters
Natick, Massachusetts
Incorporated
Delaware in 2023
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    11 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Allurion Technologies.

    Latest FDA decisions

    Search the Clearance Tracker

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT07684664 · 250 participants (planned) · Start Jul 15, 2026 · Primary completion Feb 19, 2029

      Device: Active Elipse Device · For: Obesity (BMI>30); Obesity & Overweight

    • NCT05368259 · 1,000 participants (planned) · Start May 12, 2022 · Primary completion Nov 1, 2024

      Device: AGBS · For: Obesity

      Sites: Scottsdale, Arizona; Los Angeles, California; Aurora, Colorado · 17 sites in all

    • THE ENLIGHTEN STUDYPivotal-lookingCompleted

      NCT03261453 · 400 participants · Start Feb 1, 2018 · Primary completion May 1, 2019

      Device: Active Elipse Device; Elipse Sham Device · For: Obesity; Overweight

      Sites: Scottsdale, Arizona; Aurora, Colorado; Bolingbrook, Illinois · 12 sites in all

    2 more trials with a free account

    Reports received

    18

    Received Nov 1, 2025 to Nov 20, 2026

    Malfunction reports

    6

    33% of reports

    Injury reports

    12

    67% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230000
    Jan 240000
    Feb 240000
    Mar 240000
    Apr 240000
    May 240000
    Jun 240000
    Jul 240000
    Aug 240000
    Sep 240000
    Oct 240000
    Nov 240000
    Dec 240000
    Jan 250000
    Feb 250000
    Mar 250000
    Apr 250000
    May 250000
    Jun 250000
    Jul 250000
    Aug 250000
    Sep 250000
    Oct 250000
    Nov 250000
    Dec 250000
    Jan 260000
    Feb 260000
    Mar 260000
    Apr 262000
    May 261200
    Jun 262100
    Jul 261000
    Aug 260200
    Sep 260500
    Oct 260200
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    No recalls under this name in FDA's data.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.